T. Kronvall

Non-vitamin K antagonist oral anticoagulants (NOACs) for thromboembolic prevention, are they safe in congenital heart disease? Results of a worldwide study.

M. Schwerzmann, K. Dimopoulos, B. Mulder, 2020, International journal of cardiology.

Hepatotoxicity by bosentan in a patient with portopulmonary hypertension: a case-report and review of the literature.

C. Tysk, A. Gustavsson, T. Kronvall, 2011, Journal of gastrointestinal and liver diseases : JGLD.

Epidemiological changes in Eisenmenger syndrome in the Nordic region in 1977–2012

M. Dellborg, B. Johansson, K. Sørensen, 2017, Heart.

Sinus rhythm maintenance following DC cardioversion of atrial fibrillation is not improved by temporary precardioversion treatment with oral verapamil

S. Olsson, P. Platonov, N. Edvardsson, 2004, Heart.

Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF)

P. Ponikowski, S. Solomon, M. Pfeffer, 2013, European journal of heart failure.